1	Shortly	_	RB	_	_	9	VMOD	_	_
2	after	_	IN	_	_	1	AMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	discovery	_	NN	_	_	2	PMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	APOBEC3G	_	NN	_	_	5	PMOD	_	_
7	,	_	,	_	_	9	P	_	_
8	it	_	PRP	_	_	9	VMOD	_	_
9	became	_	VBD	_	_	0	ROOT	_	_
10	clear	_	JJ	_	_	9	VMOD	_	_
11	that	_	IN	_	_	9	VMOD	_	_
12	this	_	DT	_	_	14	NMOD	_	_
13	human	_	JJ	_	_	14	NMOD	_	_
14	gene	_	NN	_	_	15	VMOD	_	_
15	plays	_	VBZ	_	_	11	SUB	_	_
16	an	_	DT	_	_	18	NMOD	_	_
17	important	_	JJ	_	_	18	NMOD	_	_
18	role	_	NN	_	_	15	VMOD	_	_
19	in	_	IN	_	_	15	VMOD	_	_
20	antiretroviral	_	JJ	_	_	21	NMOD	_	_
21	defense	_	NN	_	_	19	PMOD	_	_
22	(	_	(	_	_	23	P	_	_
23	4	_	CD	_	_	21	PRN	_	_
24	)	_	)	_	_	23	P	_	_
25	.	_	.	_	_	9	P	_	_
		
1	Originally	_	RB	_	_	2	VMOD	_	_
2	identified	_	VBN	_	_	0	ROOT	_	_
3	as	_	IN	_	_	2	VMOD	_	_
4	a	_	DT	_	_	6	NMOD	_	_
5	restriction	_	NN	_	_	6	NMOD	_	_
6	factor	_	NN	_	_	3	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	HIV-1	_	NN	_	_	9	NMOD	_	_
9	infection	_	NN	_	_	7	PMOD	_	_
10	,	_	,	_	_	2	P	_	_
11	expression	_	NN	_	_	14	VMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	APOBEC3G	_	NN	_	_	12	PMOD	_	_
14	was	_	VBD	_	_	2	COORD	_	_
15	found	_	VBN	_	_	14	VC	_	_
16	in	_	IN	_	_	15	VMOD	_	_
17	human	_	JJ	_	_	20	NMOD	_	_
18	peripheral	_	JJ	_	_	20	NMOD	_	_
19	blood	_	NN	_	_	20	NMOD	_	_
20	lymphocytes	_	NNS	_	_	16	PMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	macrophages	_	NNS	_	_	21	CONJ	_	_
23	,	_	,	_	_	20	P	_	_
24	which	_	WDT	_	_	25	VMOD	_	_
25	represent	_	VBP	_	_	20	NMOD	_	_
26	the	_	DT	_	_	29	NMOD	_	_
27	main	_	JJ	_	_	29	NMOD	_	_
28	target	_	NN	_	_	29	NMOD	_	_
29	cells	_	NNS	_	_	25	VMOD	_	_
30	for	_	IN	_	_	29	NMOD	_	_
31	HIV-1	_	NN	_	_	30	PMOD	_	_
32	(	_	(	_	_	33	P	_	_
33	32	_	CD	_	_	25	PRN	_	_
34	)	_	)	_	_	33	P	_	_
35	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	0	ROOT	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	1	P	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	protein	_	NN	_	_	6	VMOD	_	_
6	was	_	VBD	_	_	1	COORD	_	_
7	detected	_	VBN	_	_	6	VC	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	lung	_	NN	_	_	8	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	liver	_	NN	_	_	9	COORD	_	_
12	,	_	,	_	_	11	P	_	_
13	spleen	_	NN	_	_	11	COORD	_	_
14	,	_	,	_	_	13	P	_	_
15	testis	_	NN	_	_	13	COORD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	ovary	_	NN	_	_	16	CONJ	_	_
18	,	_	,	_	_	6	P	_	_
19	but	_	CC	_	_	6	COORD	_	_
20	little	_	JJ	_	_	21	VMOD	_	_
21	is	_	VBZ	_	_	19	CONJ	_	_
22	known	_	VBN	_	_	21	VC	_	_
23	about	_	IN	_	_	22	VMOD	_	_
24	its	_	PRP$	_	_	26	NMOD	_	_
25	transcriptional	_	JJ	_	_	26	NMOD	_	_
26	regulation	_	NN	_	_	23	PMOD	_	_
27	(	_	(	_	_	28	P	_	_
28	29,32,47	_	NN	_	_	26	PRN	_	_
29	)	_	)	_	_	28	P	_	_
30	.	_	.	_	_	1	P	_	_
		
1	To	_	TO	_	_	7	VMOD	_	_
2	address	_	VB	_	_	1	IM	_	_
3	this	_	DT	_	_	4	NMOD	_	_
4	question	_	NN	_	_	2	VMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	we	_	PRP	_	_	7	VMOD	_	_
7	cloned	_	VBD	_	_	0	ROOT	_	_
8	the	_	DT	_	_	11	NMOD	_	_
9	human	_	JJ	_	_	11	NMOD	_	_
10	APOBEC3G	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	7	VMOD	_	_
12	and	_	CC	_	_	7	COORD	_	_
13	analyzed	_	VBD	_	_	12	CONJ	_	_
14	its	_	PRP$	_	_	15	NMOD	_	_
15	regulation	_	NN	_	_	13	VMOD	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	T	_	NN	_	_	18	NMOD	_	_
18	cells	_	NNS	_	_	16	PMOD	_	_
19	.	_	.	_	_	7	P	_	_
		
1	Applying	_	VBG	_	_	5	VMOD	_	_
2	5'-RACE	_	NN	_	_	1	VMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	we	_	PRP	_	_	5	VMOD	_	_
5	identified	_	VBD	_	_	0	ROOT	_	_
6	multiple	_	JJ	_	_	8	NMOD	_	_
7	start	_	NN	_	_	8	NMOD	_	_
8	sites	_	NNS	_	_	5	VMOD	_	_
9	for	_	IN	_	_	8	NMOD	_	_
10	transcription	_	NN	_	_	9	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	A3G	_	NN	_	_	14	NMOD	_	_
14	gene	_	NN	_	_	11	PMOD	_	_
15	.	_	.	_	_	5	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	observation	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	consistent	_	JJ	_	_	3	VMOD	_	_
5	with	_	IN	_	_	4	AMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	fact	_	NN	_	_	5	PMOD	_	_
8	that	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	gene	_	NN	_	_	11	VMOD	_	_
11	appears	_	VBZ	_	_	8	SUB	_	_
12	to	_	TO	_	_	11	VMOD	_	_
13	lack	_	VBP	_	_	12	IM	_	_
14	canonical	_	JJ	_	_	18	NMOD	_	_
15	CCAAT	_	NN	_	_	18	NMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	TATA	_	NN	_	_	16	CONJ	_	_
18	boxes	_	NNS	_	_	13	VMOD	_	_
19	(	_	(	_	_	20	P	_	_
20	32	_	CD	_	_	18	PRN	_	_
21	)	_	)	_	_	20	P	_	_
22	,	_	,	_	_	18	P	_	_
23	a	_	DT	_	_	24	NMOD	_	_
24	condition	_	NN	_	_	18	APPO	_	_
25	often	_	RB	_	_	26	VMOD	_	_
26	associated	_	VBN	_	_	24	APPO	_	_
27	with	_	IN	_	_	26	VMOD	_	_
28	multiple	_	JJ	_	_	31	NMOD	_	_
29	transcriptional	_	JJ	_	_	31	NMOD	_	_
30	start	_	NN	_	_	31	NMOD	_	_
31	sites	_	NNS	_	_	27	PMOD	_	_
32	(	_	(	_	_	33	P	_	_
33	49-51	_	NN	_	_	31	PRN	_	_
34	)	_	)	_	_	33	P	_	_
35	.	_	.	_	_	3	P	_	_
		
1	However	_	RB	_	_	7	VMOD	_	_
2	,	_	,	_	_	7	P	_	_
3	one	_	CD	_	_	6	NMOD	_	_
4	single	_	JJ	_	_	6	NMOD	_	_
5	start	_	NN	_	_	6	NMOD	_	_
6	site	_	NN	_	_	7	VMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	detected	_	VBN	_	_	7	VC	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	6	_	CD	_	_	12	DEP	_	_
11	of	_	IN	_	_	12	DEP	_	_
12	19	_	CD	_	_	13	NMOD	_	_
13	clones	_	NNS	_	_	9	PMOD	_	_
14	and	_	CC	_	_	7	COORD	_	_
15	was	_	VBD	_	_	14	CONJ	_	_
16	designated	_	VBN	_	_	15	VC	_	_
17	as	_	IN	_	_	16	VMOD	_	_
18	+1	_	NN	_	_	17	PMOD	_	_
19	.	_	.	_	_	7	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	TSS	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	located	_	JJ	_	_	7	AMOD	_	_
5	66	_	CD	_	_	6	NMOD	_	_
6	bp	_	NN	_	_	7	AMOD	_	_
7	upstream	_	RB	_	_	3	VMOD	_	_
8	of	_	IN	_	_	7	AMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	start	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	published	_	VBN	_	_	15	NMOD	_	_
14	mRNA	_	NN	_	_	15	NMOD	_	_
15	sequence	_	NN	_	_	11	PMOD	_	_
16	(	_	(	_	_	18	P	_	_
17	GenBank(TM)	_	CD	_	_	18	NMOD	_	_
18	NM021822	_	NN	_	_	15	PRN	_	_
19	)	_	)	_	_	18	P	_	_
20	.	_	.	_	_	3	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	cloned	_	VBD	_	_	0	ROOT	_	_
3	a	_	DT	_	_	6	NMOD	_	_
4	1025	_	CD	_	_	5	AMOD	_	_
5	bp	_	NN	_	_	6	NMOD	_	_
6	promoter	_	NN	_	_	2	VMOD	_	_
7	,	_	,	_	_	6	P	_	_
8	which	_	WDT	_	_	9	VMOD	_	_
9	ranges	_	VBZ	_	_	6	NMOD	_	_
10	from	_	IN	_	_	9	VMOD	_	_
11	position	_	NN	_	_	10	PMOD	_	_
12	-959/+66	_	CD	_	_	11	NMOD	_	_
13	relative	_	JJ	_	_	14	DEP	_	_
14	to	_	TO	_	_	9	VMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	identified	_	VBN	_	_	17	NMOD	_	_
17	TSS	_	NNS	_	_	14	PMOD	_	_
18	.	_	.	_	_	2	P	_	_
		
1	Luciferase	_	NN	_	_	3	NMOD	_	_
2	reporter	_	NN	_	_	3	NMOD	_	_
3	assays	_	NNS	_	_	4	VMOD	_	_
4	showed	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	this	_	DT	_	_	7	NMOD	_	_
7	promoter	_	NN	_	_	8	VMOD	_	_
8	was	_	VBD	_	_	5	SUB	_	_
9	transcriptionally	_	RB	_	_	10	AMOD	_	_
10	active	_	JJ	_	_	8	VMOD	_	_
11	in	_	IN	_	_	10	AMOD	_	_
12	A3.01	_	NN	_	_	14	NMOD	_	_
13	T	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	11	PMOD	_	_
15	.	_	.	_	_	4	P	_	_
		
1	Treatment	_	NN	_	_	7	VMOD	_	_
2	with	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	6	NMOD	_	_
4	phorbol	_	NN	_	_	6	NMOD	_	_
5	ester	_	NN	_	_	6	NMOD	_	_
6	TPA	_	NN	_	_	2	PMOD	_	_
7	did	_	VBD	_	_	0	ROOT	_	_
8	not	_	RB	_	_	7	VMOD	_	_
9	further	_	RB	_	_	7	VMOD	_	_
10	enhance	_	VB	_	_	7	VC	_	_
11	transcriptional	_	JJ	_	_	12	NMOD	_	_
12	activity	_	NN	_	_	10	VMOD	_	_
13	,	_	,	_	_	7	P	_	_
14	although	_	IN	_	_	7	VMOD	_	_
15	upregulation	_	NN	_	_	25	VMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	A3G	_	NN	_	_	19	NMOD	_	_
18	mRNA	_	NN	_	_	19	NMOD	_	_
19	levels	_	NNS	_	_	16	PMOD	_	_
20	in	_	IN	_	_	19	NMOD	_	_
21	T	_	NN	_	_	22	NMOD	_	_
22	cells	_	NNS	_	_	20	PMOD	_	_
23	by	_	IN	_	_	15	NMOD	_	_
24	TPA	_	NN	_	_	23	PMOD	_	_
25	has	_	VBZ	_	_	14	SUB	_	_
26	been	_	VBN	_	_	25	VC	_	_
27	described	_	VBN	_	_	26	VC	_	_
28	(	_	(	_	_	29	P	_	_
29	33	_	CD	_	_	27	PRN	_	_
30	)	_	)	_	_	29	P	_	_
31	.	_	.	_	_	7	P	_	_
		
1	Rose	_	NN	_	_	4	VMOD	_	_
2	et	_	FW	_	_	1	NMOD	_	_
3	al.	_	FW	_	_	2	AMOD	_	_
4	used	_	VBD	_	_	0	ROOT	_	_
5	actinomycin	_	NN	_	_	6	NMOD	_	_
6	D	_	NN	_	_	4	VMOD	_	_
7	to	_	TO	_	_	4	VMOD	_	_
8	block	_	VB	_	_	7	IM	_	_
9	further	_	RB	_	_	8	VMOD	_	_
10	transcription	_	NN	_	_	8	VMOD	_	_
11	and	_	CC	_	_	7	COORD	_	_
12	did	_	VBD	_	_	11	CONJ	_	_
13	not	_	RB	_	_	12	VMOD	_	_
14	find	_	VB	_	_	12	VC	_	_
15	evidence	_	NN	_	_	14	VMOD	_	_
16	for	_	IN	_	_	15	NMOD	_	_
17	enhanced	_	VBN	_	_	19	NMOD	_	_
18	mRNA	_	NN	_	_	19	NMOD	_	_
19	stability	_	NN	_	_	16	PMOD	_	_
20	.	_	.	_	_	4	P	_	_
		
1	Therefore	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	authors	_	NNS	_	_	5	VMOD	_	_
5	suggested	_	VBD	_	_	0	ROOT	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	an	_	DT	_	_	10	NMOD	_	_
8	enhanced	_	VBN	_	_	10	NMOD	_	_
9	transcription	_	NN	_	_	10	NMOD	_	_
10	rate	_	NN	_	_	11	VMOD	_	_
11	could	_	MD	_	_	6	SUB	_	_
12	be	_	VB	_	_	11	VC	_	_
13	responsible	_	JJ	_	_	12	VMOD	_	_
14	for	_	IN	_	_	13	AMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	increased	_	VBN	_	_	17	NMOD	_	_
17	amount	_	NN	_	_	14	PMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	A3G	_	NN	_	_	20	NMOD	_	_
20	mRNA	_	NN	_	_	18	PMOD	_	_
21	after	_	IN	_	_	17	NMOD	_	_
22	TPA	_	NN	_	_	23	NMOD	_	_
23	treatment	_	NN	_	_	21	PMOD	_	_
24	.	_	.	_	_	5	P	_	_
		
1	However	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	promoter	_	NN	_	_	5	NMOD	_	_
5	analysis	_	NN	_	_	8	VMOD	_	_
6	we	_	PRP	_	_	5	APPO	_	_
7	performed	_	VBN	_	_	5	APPO	_	_
8	indicates	_	VBZ	_	_	0	ROOT	_	_
9	a	_	DT	_	_	11	NMOD	_	_
10	different	_	JJ	_	_	11	NMOD	_	_
11	mechanism	_	NN	_	_	8	VMOD	_	_
12	that	_	WDT	_	_	13	VMOD	_	_
13	is	_	VBZ	_	_	11	NMOD	_	_
14	independent	_	JJ	_	_	13	VMOD	_	_
15	of	_	IN	_	_	14	AMOD	_	_
16	transcriptional	_	JJ	_	_	17	NMOD	_	_
17	regulation	_	NN	_	_	15	PMOD	_	_
18	.	_	.	_	_	8	P	_	_
		
1	In	_	IN	_	_	5	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	we	_	PRP	_	_	5	VMOD	_	_
5	observed	_	VBD	_	_	0	ROOT	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	A3G	_	NN	_	_	9	NMOD	_	_
9	promoter	_	NN	_	_	10	VMOD	_	_
10	was	_	VBD	_	_	6	SUB	_	_
11	not	_	RB	_	_	10	VMOD	_	_
12	inducible	_	JJ	_	_	10	VMOD	_	_
13	by	_	IN	_	_	12	AMOD	_	_
14	IFN-alpha	_	NN	_	_	13	PMOD	_	_
15	or	_	CC	_	_	14	COORD	_	_
16	IFN-gamma	_	NN	_	_	15	CONJ	_	_
17	in	_	IN	_	_	12	AMOD	_	_
18	A3.01	_	NN	_	_	20	NMOD	_	_
19	T	_	NN	_	_	20	NMOD	_	_
20	cells	_	NNS	_	_	17	PMOD	_	_
21	,	_	,	_	_	10	P	_	_
22	whereas	_	IN	_	_	10	VMOD	_	_
23	in	_	IN	_	_	33	VMOD	_	_
24	the	_	DT	_	_	27	NMOD	_	_
25	hepatic	_	JJ	_	_	27	NMOD	_	_
26	cell	_	NN	_	_	27	NMOD	_	_
27	line	_	NN	_	_	23	PMOD	_	_
28	HepG2	_	CD	_	_	27	NMOD	_	_
29	,	_	,	_	_	33	P	_	_
30	a	_	DT	_	_	32	NMOD	_	_
31	moderate	_	JJ	_	_	32	NMOD	_	_
32	induction	_	NN	_	_	33	VMOD	_	_
33	was	_	VBD	_	_	22	SUB	_	_
34	measured	_	VBN	_	_	33	VC	_	_
35	.	_	.	_	_	5	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	has	_	VBZ	_	_	0	ROOT	_	_
3	been	_	VBN	_	_	2	VC	_	_
4	described	_	VBN	_	_	3	VC	_	_
5	previously	_	RB	_	_	4	VMOD	_	_
6	that	_	IN	_	_	4	VMOD	_	_
7	A3G	_	NN	_	_	9	NMOD	_	_
8	gene	_	NN	_	_	9	NMOD	_	_
9	expression	_	NN	_	_	10	VMOD	_	_
10	is	_	VBZ	_	_	6	SUB	_	_
11	upregulated	_	VBN	_	_	10	VC	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	interferons	_	NNS	_	_	12	PMOD	_	_
14	in	_	IN	_	_	11	VMOD	_	_
15	hepatocytes	_	NNS	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	macrophages	_	NNS	_	_	16	CONJ	_	_
18	(	_	(	_	_	19	P	_	_
19	46-48	_	CD	_	_	11	PRN	_	_
20	,	_	,	_	_	19	P	_	_
21	52	_	CD	_	_	19	COORD	_	_
22	)	_	)	_	_	19	P	_	_
23	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	this	_	DT	_	_	3	NMOD	_	_
3	context	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	8	P	_	_
5	two	_	CD	_	_	7	NMOD	_	_
6	interferon-responsive	_	JJ	_	_	7	NMOD	_	_
7	elements	_	NNS	_	_	8	VMOD	_	_
8	have	_	VBP	_	_	0	ROOT	_	_
9	been	_	VBN	_	_	8	VC	_	_
10	identified	_	VBN	_	_	9	VC	_	_
11	at	_	IN	_	_	10	VMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	positions	_	NNS	_	_	11	PMOD	_	_
14	-6/+9	_	CD	_	_	13	NMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	+1/+15	_	CD	_	_	15	CONJ	_	_
17	relative	_	JJ	_	_	13	APPO	_	_
18	to	_	TO	_	_	17	AMOD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	TSS	_	NN	_	_	18	PMOD	_	_
21	(	_	(	_	_	22	P	_	_
22	48	_	CD	_	_	20	PRN	_	_
23	)	_	)	_	_	22	P	_	_
24	.	_	.	_	_	8	P	_	_
		
1	Consistent	_	JJ	_	_	7	VMOD	_	_
2	with	_	IN	_	_	1	AMOD	_	_
3	this	_	DT	_	_	4	NMOD	_	_
4	data	_	NN	_	_	2	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	we	_	PRP	_	_	7	VMOD	_	_
7	observed	_	VBD	_	_	0	ROOT	_	_
8	an	_	DT	_	_	10	NMOD	_	_
9	interferon	_	NN	_	_	10	NMOD	_	_
10	induction	_	NN	_	_	7	VMOD	_	_
11	in	_	IN	_	_	10	NMOD	_	_
12	hepatocytes	_	NNS	_	_	11	PMOD	_	_
13	for	_	IN	_	_	10	NMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	fragments	_	NNS	_	_	13	PMOD	_	_
16	ranging	_	VBG	_	_	15	APPO	_	_
17	between	_	IN	_	_	16	VMOD	_	_
18	1025	_	CD	_	_	22	NMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	120	_	CD	_	_	19	CONJ	_	_
21	bp	_	NN	_	_	22	NMOD	_	_
22	length	_	NN	_	_	17	PMOD	_	_
23	.	_	.	_	_	7	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	activity	_	NN	_	_	14	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	the	_	DT	_	_	7	NMOD	_	_
5	60	_	CD	_	_	7	NMOD	_	_
6	bp	_	NN	_	_	7	NMOD	_	_
7	fragment	_	NN	_	_	3	PMOD	_	_
8	that	_	WDT	_	_	9	VMOD	_	_
9	does	_	VBZ	_	_	7	NMOD	_	_
10	not	_	RB	_	_	9	VMOD	_	_
11	contain	_	VB	_	_	9	VC	_	_
12	these	_	DT	_	_	13	NMOD	_	_
13	motifs	_	NNS	_	_	11	VMOD	_	_
14	was	_	VBD	_	_	0	ROOT	_	_
15	not	_	RB	_	_	14	VMOD	_	_
16	affected	_	VBN	_	_	14	VC	_	_
17	.	_	.	_	_	14	P	_	_
		
1	Thus	_	RB	_	_	7	VMOD	_	_
2	,	_	,	_	_	7	P	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	induction	_	NN	_	_	7	VMOD	_	_
5	we	_	PRP	_	_	4	APPO	_	_
6	observed	_	VBN	_	_	4	APPO	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	most	_	RBS	_	_	9	AMOD	_	_
9	likely	_	RB	_	_	7	VMOD	_	_
10	mediated	_	VBN	_	_	7	VC	_	_
11	by	_	IN	_	_	10	VMOD	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	described	_	VBN	_	_	15	NMOD	_	_
14	interferon-responsive	_	JJ	_	_	15	NMOD	_	_
15	elements	_	NNS	_	_	11	PMOD	_	_
16	.	_	.	_	_	7	P	_	_
		
1	However	_	RB	_	_	10	VMOD	_	_
2	,	_	,	_	_	10	P	_	_
3	according	_	VBG	_	_	10	VMOD	_	_
4	to	_	TO	_	_	3	PMOD	_	_
5	our	_	PRP$	_	_	6	NMOD	_	_
6	results	_	NNS	_	_	4	PMOD	_	_
7	,	_	,	_	_	10	P	_	_
8	these	_	DT	_	_	9	NMOD	_	_
9	motifs	_	NNS	_	_	10	VMOD	_	_
10	can	_	MD	_	_	0	ROOT	_	_
11	enhance	_	VB	_	_	10	VC	_	_
12	transcription	_	NN	_	_	11	VMOD	_	_
13	in	_	IN	_	_	12	NMOD	_	_
14	hepatic	_	JJ	_	_	15	NMOD	_	_
15	cells	_	NNS	_	_	13	PMOD	_	_
16	,	_	,	_	_	13	P	_	_
17	but	_	CC	_	_	13	COORD	_	_
18	not	_	RB	_	_	19	DEP	_	_
19	in	_	IN	_	_	17	CONJ	_	_
20	T	_	NN	_	_	21	NMOD	_	_
21	cells	_	NNS	_	_	19	PMOD	_	_
22	.	_	.	_	_	10	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	surprising	_	JJ	_	_	2	VMOD	_	_
4	,	_	,	_	_	2	P	_	_
5	since	_	IN	_	_	2	VMOD	_	_
6	IFN-alpha-inducible	_	JJ	_	_	8	NMOD	_	_
7	signaling	_	NN	_	_	8	NMOD	_	_
8	cascades	_	NNS	_	_	9	VMOD	_	_
9	are	_	VBP	_	_	5	SUB	_	_
10	present	_	JJ	_	_	9	VMOD	_	_
11	in	_	IN	_	_	10	AMOD	_	_
12	A3.01	_	NN	_	_	14	NMOD	_	_
13	T	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	11	PMOD	_	_
15	:	_	:	_	_	9	P	_	_
16	we	_	PRP	_	_	17	VMOD	_	_
17	showed	_	VBD	_	_	9	COORD	_	_
18	that	_	IN	_	_	17	VMOD	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	control	_	JJ	_	_	21	NMOD	_	_
21	plasmid	_	NN	_	_	26	VMOD	_	_
22	harboring	_	VBG	_	_	21	APPO	_	_
23	interferon-responsive	_	JJ	_	_	25	NMOD	_	_
24	GAS	_	NN	_	_	25	NMOD	_	_
25	elements	_	NNS	_	_	22	VMOD	_	_
26	was	_	VBD	_	_	18	SUB	_	_
27	markedly	_	RB	_	_	26	VMOD	_	_
28	induced	_	VBN	_	_	26	VC	_	_
29	by	_	IN	_	_	28	VMOD	_	_
30	IFN-alpha	_	NN	_	_	31	NMOD	_	_
31	treatment	_	NN	_	_	29	PMOD	_	_
32	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	7	P	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	GAS	_	NN	_	_	6	NMOD	_	_
6	element	_	NN	_	_	7	VMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	not	_	RB	_	_	7	VMOD	_	_
9	responsive	_	JJ	_	_	7	VMOD	_	_
10	to	_	TO	_	_	9	AMOD	_	_
11	IFN-gamma	_	NN	_	_	12	NMOD	_	_
12	treatment	_	NN	_	_	10	PMOD	_	_
13	in	_	IN	_	_	12	NMOD	_	_
14	these	_	DT	_	_	15	NMOD	_	_
15	cells	_	NNS	_	_	13	PMOD	_	_
16	,	_	,	_	_	7	P	_	_
17	suggesting	_	VBG	_	_	7	VC	_	_
18	that	_	IN	_	_	17	VMOD	_	_
19	our	_	PRP$	_	_	22	NMOD	_	_
20	T	_	NN	_	_	22	NMOD	_	_
21	cell	_	NN	_	_	22	NMOD	_	_
22	line	_	NN	_	_	23	VMOD	_	_
23	was	_	VBD	_	_	18	SUB	_	_
24	not	_	RB	_	_	23	VMOD	_	_
25	able	_	JJ	_	_	23	VMOD	_	_
26	to	_	TO	_	_	25	AMOD	_	_
27	mediate	_	VB	_	_	26	IM	_	_
28	IFN-gamma-induced	_	JJ	_	_	29	NMOD	_	_
29	signals	_	NNS	_	_	27	VMOD	_	_
30	.	_	.	_	_	7	P	_	_
		
1	So	_	RB	_	_	10	VMOD	_	_
2	far	_	RB	_	_	1	AMOD	_	_
3	,	_	,	_	_	10	P	_	_
4	enhanced	_	VBN	_	_	7	NMOD	_	_
5	A3G	_	NN	_	_	7	NMOD	_	_
6	promoter	_	NN	_	_	7	NMOD	_	_
7	activity	_	NN	_	_	10	VMOD	_	_
8	by	_	IN	_	_	7	NMOD	_	_
9	interferons	_	NNS	_	_	8	PMOD	_	_
10	is	_	VBZ	_	_	0	ROOT	_	_
11	clearly	_	RB	_	_	10	VMOD	_	_
12	described	_	VBN	_	_	10	VC	_	_
13	in	_	IN	_	_	12	VMOD	_	_
14	hepatocytes	_	NNS	_	_	13	PMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	macrophages	_	NNS	_	_	15	CONJ	_	_
17	,	_	,	_	_	10	P	_	_
18	whereas	_	IN	_	_	10	COORD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	situation	_	NN	_	_	24	VMOD	_	_
21	in	_	IN	_	_	20	NMOD	_	_
22	T	_	NN	_	_	23	NMOD	_	_
23	cells	_	NNS	_	_	21	PMOD	_	_
24	is	_	VBZ	_	_	18	COORD	_	_
25	still	_	RB	_	_	24	VMOD	_	_
26	unclear	_	JJ	_	_	24	VMOD	_	_
27	.	_	.	_	_	10	P	_	_
		
1	A	_	DT	_	_	3	NMOD	_	_
2	recent	_	JJ	_	_	3	NMOD	_	_
3	study	_	NN	_	_	4	VMOD	_	_
4	found	_	VBD	_	_	0	ROOT	_	_
5	no	_	DT	_	_	6	NMOD	_	_
6	influence	_	NN	_	_	4	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	IFN-alpha	_	NN	_	_	7	PMOD	_	_
9	or	_	CC	_	_	8	COORD	_	_
10	IFN-gamma	_	NN	_	_	9	CONJ	_	_
11	on	_	IN	_	_	6	NMOD	_	_
12	A3G	_	NN	_	_	13	NMOD	_	_
13	expression	_	NN	_	_	11	PMOD	_	_
14	in	_	IN	_	_	13	NMOD	_	_
15	resting	_	VBG	_	_	18	NMOD	_	_
16	primary	_	JJ	_	_	18	NMOD	_	_
17	blood	_	NN	_	_	18	NMOD	_	_
18	lymphocytes	_	NNS	_	_	14	PMOD	_	_
19	(	_	(	_	_	20	P	_	_
20	52	_	CD	_	_	18	PRN	_	_
21	)	_	)	_	_	20	P	_	_
22	.	_	.	_	_	4	P	_	_
		
1	Another	_	DT	_	_	2	NMOD	_	_
2	publication	_	NN	_	_	3	VMOD	_	_
3	describes	_	VBZ	_	_	0	ROOT	_	_
4	an	_	DT	_	_	6	NMOD	_	_
5	enhanced	_	VBN	_	_	6	NMOD	_	_
6	expression	_	NN	_	_	3	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	A3G	_	NN	_	_	7	PMOD	_	_
9	after	_	IN	_	_	8	NMOD	_	_
10	IFN-alpha	_	NN	_	_	11	NMOD	_	_
11	treatment	_	NN	_	_	9	PMOD	_	_
12	in	_	IN	_	_	6	NMOD	_	_
13	resting	_	VBG	_	_	17	NMOD	_	_
14	primary	_	JJ	_	_	17	NMOD	_	_
15	CD4	_	NN	_	_	17	NMOD	_	_
16	T	_	NN	_	_	17	NMOD	_	_
17	cells	_	NNS	_	_	12	PMOD	_	_
18	,	_	,	_	_	12	P	_	_
19	but	_	CC	_	_	12	COORD	_	_
20	not	_	RB	_	_	21	DEP	_	_
21	in	_	IN	_	_	19	CONJ	_	_
22	activated	_	VBN	_	_	24	NMOD	_	_
23	T	_	NN	_	_	24	NMOD	_	_
24	cells	_	NNS	_	_	21	PMOD	_	_
25	(	_	(	_	_	26	P	_	_
26	53	_	CD	_	_	24	PRN	_	_
27	)	_	)	_	_	26	P	_	_
28	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	observation	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	not	_	RB	_	_	3	VMOD	_	_
5	contradictory	_	JJ	_	_	3	VMOD	_	_
6	to	_	TO	_	_	5	AMOD	_	_
7	our	_	PRP$	_	_	8	NMOD	_	_
8	results	_	NNS	_	_	6	PMOD	_	_
9	since	_	IN	_	_	3	VMOD	_	_
10	T	_	NN	_	_	12	NMOD	_	_
11	cell	_	NN	_	_	12	NMOD	_	_
12	lines	_	NNS	_	_	13	VMOD	_	_
13	are	_	VBP	_	_	9	SUB	_	_
14	mitotically	_	RB	_	_	15	AMOD	_	_
15	active	_	JJ	_	_	13	VMOD	_	_
16	and	_	CC	_	_	13	COORD	_	_
17	therefore	_	RB	_	_	13	VMOD	_	_
18	rather	_	RB	_	_	13	VMOD	_	_
19	in	_	IN	_	_	13	VMOD	_	_
20	an	_	DT	_	_	22	NMOD	_	_
21	activated	_	VBN	_	_	22	NMOD	_	_
22	than	_	IN	_	_	19	PMOD	_	_
23	in	_	IN	_	_	22	NMOD	_	_
24	a	_	DT	_	_	26	NMOD	_	_
25	resting	_	JJ	_	_	26	NMOD	_	_
26	state	_	NN	_	_	23	PMOD	_	_
27	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	conclusion	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	7	P	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	current	_	JJ	_	_	6	NMOD	_	_
6	data	_	NN	_	_	7	VMOD	_	_
7	suggests	_	VBZ	_	_	0	ROOT	_	_
8	that	_	IN	_	_	7	VMOD	_	_
9	regulation	_	NN	_	_	17	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	A3G	_	NN	_	_	14	NMOD	_	_
13	promoter	_	NN	_	_	14	NMOD	_	_
14	activity	_	NN	_	_	10	PMOD	_	_
15	by	_	IN	_	_	9	NMOD	_	_
16	interferons	_	NNS	_	_	15	PMOD	_	_
17	is	_	VBZ	_	_	8	SUB	_	_
18	dependent	_	JJ	_	_	17	VMOD	_	_
19	on	_	IN	_	_	18	AMOD	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	cell	_	NN	_	_	22	NMOD	_	_
22	type	_	NN	_	_	19	PMOD	_	_
23	and	_	CC	_	_	19	COORD	_	_
24	possibly	_	RB	_	_	23	CONJ	_	_
25	also	_	RB	_	_	24	AMOD	_	_
26	from	_	IN	_	_	24	COORD	_	_
27	the	_	DT	_	_	30	NMOD	_	_
28	cellular	_	JJ	_	_	30	NMOD	_	_
29	activation	_	NN	_	_	30	NMOD	_	_
30	status	_	NN	_	_	26	PMOD	_	_
31	.	_	.	_	_	7	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	additionally	_	RB	_	_	3	VMOD	_	_
3	analyzed	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	influence	_	NN	_	_	3	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	HIV-1	_	NN	_	_	8	NMOD	_	_
8	proteins	_	NNS	_	_	6	PMOD	_	_
9	on	_	IN	_	_	5	NMOD	_	_
10	A3G	_	NN	_	_	12	NMOD	_	_
11	promoter	_	NN	_	_	12	NMOD	_	_
12	activity	_	NN	_	_	9	PMOD	_	_
13	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	HIV-1	_	NN	_	_	4	NMOD	_	_
3	Vif	_	NN	_	_	4	NMOD	_	_
4	protein	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	neutralizing	_	VBG	_	_	5	VC	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	antiviral	_	JJ	_	_	9	NMOD	_	_
9	function	_	NN	_	_	6	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	A3G	_	NN	_	_	10	PMOD	_	_
12	by	_	IN	_	_	6	VMOD	_	_
13	a	_	DT	_	_	14	NMOD	_	_
14	multitude	_	NN	_	_	12	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	ways	_	NNS	_	_	15	PMOD	_	_
17	.	_	.	_	_	5	P	_	_
		
1	Targeting	_	VBG	_	_	8	VC	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	A3G	_	NN	_	_	4	NMOD	_	_
4	protein	_	NN	_	_	1	VMOD	_	_
5	for	_	IN	_	_	1	VMOD	_	_
6	proteasomal	_	JJ	_	_	7	NMOD	_	_
7	degradation	_	NN	_	_	5	PMOD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	considered	_	VBN	_	_	8	VC	_	_
10	to	_	TO	_	_	9	VMOD	_	_
11	be	_	VB	_	_	10	IM	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	main	_	JJ	_	_	14	NMOD	_	_
14	mode	_	NN	_	_	11	VMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	action	_	NN	_	_	15	PMOD	_	_
17	(	_	(	_	_	18	P	_	_
18	37-41	_	NN	_	_	16	PRN	_	_
19	)	_	)	_	_	18	P	_	_
20	,	_	,	_	_	8	P	_	_
21	but	_	CC	_	_	8	COORD	_	_
22	it	_	PRP	_	_	23	VMOD	_	_
23	becomes	_	VBZ	_	_	21	CONJ	_	_
24	more	_	RBR	_	_	23	VMOD	_	_
25	and	_	CC	_	_	24	COORD	_	_
26	more	_	RBR	_	_	25	CONJ	_	_
27	clear	_	JJ	_	_	23	VMOD	_	_
28	that	_	IN	_	_	23	VMOD	_	_
29	other	_	JJ	_	_	30	NMOD	_	_
30	mechanisms	_	NNS	_	_	31	VMOD	_	_
31	are	_	VBP	_	_	28	SUB	_	_
32	also	_	RB	_	_	31	VMOD	_	_
33	involved	_	VBN	_	_	31	VC	_	_
34	.	_	.	_	_	8	P	_	_
		
1	There	_	EX	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	evidence	_	NN	_	_	2	VMOD	_	_
4	that	_	IN	_	_	3	NMOD	_	_
5	Vif	_	NN	_	_	7	VMOD	_	_
6	also	_	RB	_	_	7	VMOD	_	_
7	promotes	_	VBZ	_	_	4	SUB	_	_
8	exclusion	_	NN	_	_	7	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	A3G	_	NN	_	_	9	PMOD	_	_
11	from	_	IN	_	_	8	NMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	virus	_	NN	_	_	14	NMOD	_	_
14	particles	_	NNS	_	_	11	PMOD	_	_
15	and	_	CC	_	_	2	COORD	_	_
16	an	_	DT	_	_	17	NMOD	_	_
17	influence	_	NN	_	_	23	VMOD	_	_
18	on	_	IN	_	_	17	NMOD	_	_
19	the	_	DT	_	_	22	NMOD	_	_
20	A3G	_	NN	_	_	22	NMOD	_	_
21	translation	_	NN	_	_	22	NMOD	_	_
22	process	_	NN	_	_	18	PMOD	_	_
23	is	_	VBZ	_	_	15	CONJ	_	_
24	discussed	_	VBN	_	_	23	VC	_	_
25	(	_	(	_	_	26	P	_	_
26	8,42,43	_	NN	_	_	24	PRN	_	_
27	)	_	)	_	_	26	P	_	_
28	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	question	_	NN	_	_	12	VMOD	_	_
3	whether	_	IN	_	_	2	NMOD	_	_
4	Vif	_	NN	_	_	5	VMOD	_	_
5	alters	_	VBZ	_	_	3	SUB	_	_
6	transcription	_	NN	_	_	5	VMOD	_	_
7	controlled	_	VBN	_	_	6	APPO	_	_
8	by	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	A3G	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	8	PMOD	_	_
12	has	_	VBZ	_	_	0	ROOT	_	_
13	not	_	RB	_	_	12	VMOD	_	_
14	been	_	VBN	_	_	12	VC	_	_
15	analyzed	_	VBN	_	_	14	VC	_	_
16	so	_	RB	_	_	15	VMOD	_	_
17	far	_	RB	_	_	16	AMOD	_	_
18	.	_	.	_	_	12	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	analysis	_	NN	_	_	3	VMOD	_	_
3	indicates	_	VBZ	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	transcription	_	NN	_	_	10	VMOD	_	_
6	from	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	A3G	_	NN	_	_	9	NMOD	_	_
9	promoter	_	NN	_	_	6	PMOD	_	_
10	is	_	VBZ	_	_	4	SUB	_	_
11	unaffected	_	VBN	_	_	10	VC	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	Vif	_	NN	_	_	12	PMOD	_	_
14	or	_	CC	_	_	13	COORD	_	_
15	other	_	JJ	_	_	17	NMOD	_	_
16	HIV-1	_	NN	_	_	17	NMOD	_	_
17	proteins	_	NNS	_	_	14	CONJ	_	_
18	.	_	.	_	_	3	P	_	_
		
1	Taken	_	VBN	_	_	12	VMOD	_	_
2	together	_	RB	_	_	1	VMOD	_	_
3	,	_	,	_	_	1	P	_	_
4	in	_	IN	_	_	1	VMOD	_	_
5	T	_	NN	_	_	7	NMOD	_	_
6	cell	_	NN	_	_	7	NMOD	_	_
7	lines	_	NNS	_	_	4	PMOD	_	_
8	,	_	,	_	_	12	P	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	A3G	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	12	VMOD	_	_
12	appears	_	VBZ	_	_	0	ROOT	_	_
13	constitutively	_	RB	_	_	14	AMOD	_	_
14	active	_	JJ	_	_	12	VMOD	_	_
15	.	_	.	_	_	12	P	_	_
		
1	By	_	IN	_	_	10	VMOD	_	_
2	generating	_	VBG	_	_	1	PMOD	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	series	_	NN	_	_	2	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	5'	_	JJ	_	_	7	NMOD	_	_
7	deletions	_	NNS	_	_	5	PMOD	_	_
8	,	_	,	_	_	10	P	_	_
9	we	_	PRP	_	_	10	VMOD	_	_
10	showed	_	VBD	_	_	0	ROOT	_	_
11	that	_	IN	_	_	10	VMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	core	_	NN	_	_	14	NMOD	_	_
14	promoter	_	NN	_	_	15	VMOD	_	_
15	is	_	VBZ	_	_	11	SUB	_	_
16	located	_	JJ	_	_	15	VMOD	_	_
17	within	_	IN	_	_	16	AMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	region	_	NN	_	_	17	PMOD	_	_
20	-114/+66	_	CD	_	_	19	NMOD	_	_
21	relative	_	JJ	_	_	19	APPO	_	_
22	to	_	TO	_	_	21	AMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	TSS	_	NN	_	_	22	PMOD	_	_
25	.	_	.	_	_	10	P	_	_
		
1	This	_	DT	_	_	4	NMOD	_	_
2	180	_	CD	_	_	3	AMOD	_	_
3	bp	_	NN	_	_	4	NMOD	_	_
4	promoter	_	NN	_	_	5	VMOD	_	_
5	was	_	VBD	_	_	0	ROOT	_	_
6	transcriptionally	_	RB	_	_	7	AMOD	_	_
7	active	_	JJ	_	_	5	VMOD	_	_
8	in	_	IN	_	_	7	AMOD	_	_
9	the	_	DT	_	_	16	NMOD	_	_
10	lymphoid	_	JJ	_	_	16	NMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	myeloid	_	JJ	_	_	10	COORD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	hepatic	_	JJ	_	_	13	CONJ	_	_
15	cell	_	NN	_	_	16	NMOD	_	_
16	lines	_	NNS	_	_	8	PMOD	_	_
17	we	_	PRP	_	_	16	APPO	_	_
18	tested	_	VBN	_	_	16	APPO	_	_
19	,	_	,	_	_	5	P	_	_
20	indicating	_	VBG	_	_	5	VC	_	_
21	that	_	IN	_	_	20	VMOD	_	_
22	ubiquitous	_	JJ	_	_	24	NMOD	_	_
23	transcription	_	NN	_	_	24	NMOD	_	_
24	factors	_	NNS	_	_	25	VMOD	_	_
25	are	_	VBP	_	_	21	SUB	_	_
26	involved	_	VBN	_	_	25	VC	_	_
27	in	_	IN	_	_	26	VMOD	_	_
28	regulation	_	NN	_	_	27	PMOD	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	A3G	_	NN	_	_	32	NMOD	_	_
31	gene	_	NN	_	_	32	NMOD	_	_
32	transcription	_	NN	_	_	29	PMOD	_	_
33	.	_	.	_	_	5	P	_	_
		
1	A	_	DT	_	_	2	NMOD	_	_
2	GC-box	_	NN	_	_	7	VMOD	_	_
3	with	_	IN	_	_	2	NMOD	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	sequence	_	NN	_	_	6	NMOD	_	_
6	TGGGCGGGAC	_	NN	_	_	3	PMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	identified	_	VBN	_	_	7	VC	_	_
9	at	_	IN	_	_	8	VMOD	_	_
10	position	_	NN	_	_	9	PMOD	_	_
11	-87/-78	_	CD	_	_	10	NMOD	_	_
12	of	_	IN	_	_	10	NMOD	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	A3G	_	NN	_	_	15	NMOD	_	_
15	promoter	_	NN	_	_	12	PMOD	_	_
16	.	_	.	_	_	7	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	GC-box	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	essential	_	JJ	_	_	3	VMOD	_	_
5	for	_	IN	_	_	4	AMOD	_	_
6	basal	_	JJ	_	_	8	NMOD	_	_
7	promoter	_	NN	_	_	8	NMOD	_	_
8	activity	_	NN	_	_	5	PMOD	_	_
9	,	_	,	_	_	3	P	_	_
10	since	_	IN	_	_	3	VMOD	_	_
11	changing	_	VBG	_	_	22	VMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	motif	_	NN	_	_	11	VMOD	_	_
14	to	_	TO	_	_	13	NMOD	_	_
15	TGTTCGGGAC	_	NN	_	_	14	PMOD	_	_
16	by	_	IN	_	_	11	VMOD	_	_
17	introducing	_	VBG	_	_	16	PMOD	_	_
18	two	_	CD	_	_	20	NMOD	_	_
19	point	_	NN	_	_	20	NMOD	_	_
20	mutations	_	NNS	_	_	17	VMOD	_	_
21	strongly	_	RB	_	_	22	VMOD	_	_
22	reduced	_	VBD	_	_	10	SUB	_	_
23	A3G	_	NN	_	_	25	NMOD	_	_
24	promoter	_	NN	_	_	25	NMOD	_	_
25	activity	_	NN	_	_	22	VMOD	_	_
26	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	transcriptional	_	JJ	_	_	3	NMOD	_	_
3	potency	_	NN	_	_	7	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	GC-box	_	NN	_	_	4	PMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	further	_	RB	_	_	7	VMOD	_	_
9	demonstrated	_	VBN	_	_	7	VC	_	_
10	by	_	IN	_	_	9	VMOD	_	_
11	cloning	_	VBG	_	_	10	PMOD	_	_
12	it	_	PRP	_	_	11	VMOD	_	_
13	upstream	_	RB	_	_	12	NMOD	_	_
14	of	_	IN	_	_	13	AMOD	_	_
15	an	_	DT	_	_	17	NMOD	_	_
16	SV40	_	NN	_	_	17	NMOD	_	_
17	promoter	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	7	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	resulted	_	VBD	_	_	0	ROOT	_	_
3	in	_	IN	_	_	2	VMOD	_	_
4	a	_	DT	_	_	8	NMOD	_	_
5	4-fold	_	RB	_	_	6	AMOD	_	_
6	enhanced	_	VBN	_	_	8	NMOD	_	_
7	transcription	_	NN	_	_	8	NMOD	_	_
8	rate	_	NN	_	_	3	PMOD	_	_
9	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	hypothesis	_	NN	_	_	15	VMOD	_	_
3	that	_	IN	_	_	2	NMOD	_	_
4	a	_	DT	_	_	7	NMOD	_	_
5	general	_	JJ	_	_	7	NMOD	_	_
6	transcription	_	NN	_	_	7	NMOD	_	_
7	factor	_	NN	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	3	SUB	_	_
9	involved	_	VBN	_	_	8	VC	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	regulation	_	NN	_	_	10	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	A3G	_	NN	_	_	14	NMOD	_	_
14	transcription	_	NN	_	_	12	PMOD	_	_
15	was	_	VBD	_	_	0	ROOT	_	_
16	confirmed	_	VBN	_	_	15	VC	_	_
17	by	_	IN	_	_	16	VMOD	_	_
18	EMSA	_	NN	_	_	17	PMOD	_	_
19	.	_	.	_	_	15	P	_	_
		
1	Supershift	_	NN	_	_	2	NMOD	_	_
2	analysis	_	NN	_	_	3	VMOD	_	_
3	showed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	transcription	_	NN	_	_	7	NMOD	_	_
7	factors	_	NNS	_	_	19	VMOD	_	_
8	Sp1	_	NN	_	_	7	APPO	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	Sp3	_	NN	_	_	9	CONJ	_	_
11	which	_	WDT	_	_	12	VMOD	_	_
12	are	_	VBP	_	_	7	NMOD	_	_
13	ubiquitously	_	RB	_	_	12	VMOD	_	_
14	expressed	_	VBN	_	_	12	VC	_	_
15	in	_	IN	_	_	14	VMOD	_	_
16	mammalian	_	JJ	_	_	17	NMOD	_	_
17	cells	_	NNS	_	_	15	PMOD	_	_
18	,	_	,	_	_	7	P	_	_
19	bind	_	VBP	_	_	4	SUB	_	_
20	specifically	_	RB	_	_	19	VMOD	_	_
21	to	_	TO	_	_	19	VMOD	_	_
22	the	_	DT	_	_	24	NMOD	_	_
23	identified	_	VBN	_	_	24	NMOD	_	_
24	motif	_	NN	_	_	21	PMOD	_	_
25	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	15	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	15	P	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	binding	_	NN	_	_	15	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	Sp1	_	NN	_	_	6	PMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	Sp3	_	NN	_	_	8	CONJ	_	_
10	to	_	TO	_	_	5	NMOD	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	endogenous	_	JJ	_	_	14	NMOD	_	_
13	A3G	_	NN	_	_	14	NMOD	_	_
14	promoter	_	NN	_	_	10	PMOD	_	_
15	was	_	VBD	_	_	0	ROOT	_	_
16	demonstrated	_	VBN	_	_	15	VC	_	_
17	by	_	IN	_	_	16	VMOD	_	_
18	a	_	DT	_	_	21	NMOD	_	_
19	chromatin	_	NN	_	_	21	NMOD	_	_
20	immunoprecipitation	_	NN	_	_	21	NMOD	_	_
21	assay	_	NN	_	_	17	PMOD	_	_
22	.	_	.	_	_	15	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	observation	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	consistent	_	JJ	_	_	3	VMOD	_	_
5	with	_	IN	_	_	4	AMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	results	_	NNS	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	5'-RACE	_	NN	_	_	8	PMOD	_	_
11	,	_	,	_	_	3	P	_	_
12	since	_	IN	_	_	3	VMOD	_	_
13	Sp1	_	NN	_	_	14	VMOD	_	_
14	is	_	VBZ	_	_	12	SUB	_	_
15	known	_	VBN	_	_	14	VC	_	_
16	to	_	TO	_	_	15	VMOD	_	_
17	play	_	VB	_	_	16	IM	_	_
18	an	_	DT	_	_	20	NMOD	_	_
19	important	_	JJ	_	_	20	NMOD	_	_
20	role	_	NN	_	_	17	VMOD	_	_
21	for	_	IN	_	_	20	NMOD	_	_
22	RNA	_	NN	_	_	23	NMOD	_	_
23	polymerase	_	NN	_	_	21	PMOD	_	_
24	II	_	CD	_	_	23	NMOD	_	_
25	to	_	TO	_	_	17	VMOD	_	_
26	bind	_	VB	_	_	25	IM	_	_
27	to	_	TO	_	_	26	VMOD	_	_
28	the	_	DT	_	_	31	NMOD	_	_
29	transcription	_	NN	_	_	31	NMOD	_	_
30	initiation	_	NN	_	_	31	NMOD	_	_
31	site	_	NN	_	_	27	PMOD	_	_
32	in	_	IN	_	_	31	NMOD	_	_
33	TATA-boxless	_	JJ	_	_	34	NMOD	_	_
34	promoters	_	NNS	_	_	32	PMOD	_	_
35	and	_	CC	_	_	14	COORD	_	_
36	is	_	VBZ	_	_	35	CONJ	_	_
37	associated	_	VBN	_	_	36	VC	_	_
38	with	_	IN	_	_	37	VMOD	_	_
39	multiple	_	JJ	_	_	42	NMOD	_	_
40	transcription	_	NN	_	_	42	NMOD	_	_
41	initiation	_	NN	_	_	42	NMOD	_	_
42	sites	_	NNS	_	_	38	PMOD	_	_
43	(	_	(	_	_	44	P	_	_
44	54-56	_	NN	_	_	42	PRN	_	_
45	)	_	)	_	_	44	P	_	_
46	.	_	.	_	_	3	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	also	_	RB	_	_	3	VMOD	_	_
3	tested	_	VBD	_	_	0	ROOT	_	_
4	whether	_	IN	_	_	3	VMOD	_	_
5	overexpression	_	NN	_	_	11	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	Sp1	_	NN	_	_	6	PMOD	_	_
8	or	_	CC	_	_	7	COORD	_	_
9	Sp3	_	NN	_	_	8	CONJ	_	_
10	proteins	_	NNS	_	_	9	COORD	_	_
11	had	_	VBD	_	_	4	SUB	_	_
12	an	_	DT	_	_	13	NMOD	_	_
13	influence	_	NN	_	_	11	VMOD	_	_
14	on	_	IN	_	_	13	NMOD	_	_
15	A3G	_	NN	_	_	17	NMOD	_	_
16	promoter	_	NN	_	_	17	NMOD	_	_
17	activity	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	3	P	_	_
		
1	Luciferase	_	NN	_	_	2	NMOD	_	_
2	assays	_	NNS	_	_	3	VMOD	_	_
3	revealed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	A3G	_	NN	_	_	7	NMOD	_	_
6	promoter	_	NN	_	_	7	NMOD	_	_
7	activities	_	NNS	_	_	8	VMOD	_	_
8	remained	_	VBD	_	_	4	SUB	_	_
9	unchanged	_	JJ	_	_	8	VMOD	_	_
10	(	_	(	_	_	13	P	_	_
11	data	_	NNS	_	_	13	VMOD	_	_
12	not	_	RB	_	_	13	VMOD	_	_
13	shown	_	VBN	_	_	9	PRN	_	_
14	)	_	)	_	_	13	P	_	_
15	,	_	,	_	_	8	P	_	_
16	most	_	RBS	_	_	17	AMOD	_	_
17	probably	_	RB	_	_	19	PMOD	_	_
18	due	_	JJ	_	_	19	DEP	_	_
19	to	_	TO	_	_	8	VMOD	_	_
20	the	_	DT	_	_	24	NMOD	_	_
21	high	_	JJ	_	_	24	NMOD	_	_
22	basal	_	JJ	_	_	24	NMOD	_	_
23	expression	_	NN	_	_	24	NMOD	_	_
24	level	_	NN	_	_	19	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	the	_	DT	_	_	28	NMOD	_	_
27	endogenous	_	JJ	_	_	28	NMOD	_	_
28	Sp1	_	NN	_	_	25	PMOD	_	_
29	and/or	_	CC	_	_	28	COORD	_	_
30	Sp3	_	NN	_	_	29	CONJ	_	_
31	proteins	_	NNS	_	_	30	COORD	_	_
32	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	Sp	_	NN	_	_	3	NMOD	_	_
3	family	_	NN	_	_	7	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	transcription	_	NN	_	_	6	NMOD	_	_
6	factors	_	NNS	_	_	4	PMOD	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	involved	_	VBN	_	_	7	VC	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	transcriptional	_	JJ	_	_	11	NMOD	_	_
11	regulation	_	NN	_	_	9	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	many	_	JJ	_	_	21	NMOD	_	_
14	housekeeping	_	JJ	_	_	21	NMOD	_	_
15	,	_	,	_	_	14	P	_	_
16	tissue-specific	_	JJ	_	_	14	COORD	_	_
17	,	_	,	_	_	16	P	_	_
18	viral	_	JJ	_	_	16	COORD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	inducible	_	JJ	_	_	19	CONJ	_	_
21	genes	_	NNS	_	_	12	PMOD	_	_
22	(	_	(	_	_	23	P	_	_
23	57	_	CD	_	_	21	PRN	_	_
24	)	_	)	_	_	23	P	_	_
25	.	_	.	_	_	7	P	_	_
		
1	Whereas	_	IN	_	_	10	VMOD	_	_
2	Sp1	_	NN	_	_	4	VMOD	_	_
3	typically	_	RB	_	_	4	VMOD	_	_
4	acts	_	VBZ	_	_	1	SUB	_	_
5	as	_	IN	_	_	4	VMOD	_	_
6	an	_	DT	_	_	7	NMOD	_	_
7	activator	_	NN	_	_	5	PMOD	_	_
8	,	_	,	_	_	10	P	_	_
9	Sp3	_	NN	_	_	10	VMOD	_	_
10	can	_	MD	_	_	0	ROOT	_	_
11	serve	_	VB	_	_	10	VC	_	_
12	as	_	IN	_	_	11	VMOD	_	_
13	a	_	DT	_	_	14	NMOD	_	_
14	repressor	_	NN	_	_	12	PMOD	_	_
15	or	_	CC	_	_	14	COORD	_	_
16	activator	_	NN	_	_	15	CONJ	_	_
17	(	_	(	_	_	16	P	_	_
18	57	_	CD	_	_	16	NMOD	_	_
19	)	_	)	_	_	16	P	_	_
20	.	_	.	_	_	10	P	_	_
		
1	However	_	RB	_	_	14	VMOD	_	_
2	,	_	,	_	_	14	P	_	_
3	in	_	IN	_	_	14	VMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	context	_	NN	_	_	3	PMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	A3G	_	NN	_	_	9	NMOD	_	_
9	promoter	_	NN	_	_	6	PMOD	_	_
10	,	_	,	_	_	14	P	_	_
11	both	_	DT	_	_	13	NMOD	_	_
12	transcription	_	NN	_	_	13	NMOD	_	_
13	factors	_	NNS	_	_	14	VMOD	_	_
14	serve	_	VBP	_	_	0	ROOT	_	_
15	as	_	IN	_	_	14	VMOD	_	_
16	activators	_	NNS	_	_	15	PMOD	_	_
17	,	_	,	_	_	14	P	_	_
18	as	_	IN	_	_	14	VMOD	_	_
19	shown	_	VBN	_	_	18	SUB	_	_
20	by	_	IN	_	_	19	VMOD	_	_
21	siRNA-mediated	_	JJ	_	_	22	NMOD	_	_
22	silencing	_	NN	_	_	20	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	single	_	JJ	_	_	26	NMOD	_	_
26	factors	_	NNS	_	_	23	PMOD	_	_
27	.	_	.	_	_	14	P	_	_
		
1	Although	_	IN	_	_	20	VMOD	_	_
2	siRNAs	_	NNS	_	_	9	VMOD	_	_
3	directed	_	VBN	_	_	2	APPO	_	_
4	against	_	IN	_	_	3	VMOD	_	_
5	Sp1	_	NN	_	_	4	PMOD	_	_
6	or	_	CC	_	_	5	COORD	_	_
7	Sp3	_	NN	_	_	6	CONJ	_	_
8	significantly	_	RB	_	_	9	VMOD	_	_
9	reduced	_	VBD	_	_	1	SUB	_	_
10	transcription	_	NN	_	_	9	VMOD	_	_
11	controlled	_	VBN	_	_	10	APPO	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	the	_	DT	_	_	16	NMOD	_	_
14	180	_	CD	_	_	15	AMOD	_	_
15	bp	_	NN	_	_	16	NMOD	_	_
16	promoter	_	NN	_	_	12	PMOD	_	_
17	,	_	,	_	_	20	P	_	_
18	transcriptional	_	JJ	_	_	19	NMOD	_	_
19	activity	_	NN	_	_	20	VMOD	_	_
20	was	_	VBD	_	_	0	ROOT	_	_
21	not	_	RB	_	_	20	VMOD	_	_
22	reduced	_	VBN	_	_	20	VC	_	_
23	to	_	TO	_	_	22	VMOD	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	level	_	NN	_	_	23	PMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	the	_	DT	_	_	30	NMOD	_	_
28	150	_	CD	_	_	30	NMOD	_	_
29	bp	_	NN	_	_	30	NMOD	_	_
30	fragment	_	NN	_	_	26	PMOD	_	_
31	.	_	.	_	_	20	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	can	_	MD	_	_	0	ROOT	_	_
3	be	_	VB	_	_	2	VC	_	_
4	explained	_	VBN	_	_	3	VC	_	_
5	by	_	IN	_	_	4	VMOD	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	remaining	_	VBG	_	_	9	NMOD	_	_
8	low	_	JJ	_	_	9	NMOD	_	_
9	amounts	_	NNS	_	_	5	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	Sp1/Sp3	_	NN	_	_	12	NMOD	_	_
12	proteins	_	NNS	_	_	10	PMOD	_	_
13	which	_	WDT	_	_	14	VMOD	_	_
14	can	_	MD	_	_	9	NMOD	_	_
15	be	_	VB	_	_	14	VC	_	_
16	seen	_	VBN	_	_	15	VC	_	_
17	in	_	IN	_	_	16	VMOD	_	_
18	the	_	DT	_	_	21	NMOD	_	_
19	western	_	NN	_	_	21	NMOD	_	_
20	blot	_	NN	_	_	21	NMOD	_	_
21	analysis	_	NN	_	_	17	PMOD	_	_
22	.	_	.	_	_	2	P	_	_
		
1	Alternatively	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	other	_	JJ	_	_	5	NMOD	_	_
4	transcription	_	NN	_	_	5	NMOD	_	_
5	factors	_	NNS	_	_	6	VMOD	_	_
6	could	_	MD	_	_	0	ROOT	_	_
7	be	_	VB	_	_	6	VC	_	_
8	involved	_	VBN	_	_	7	VC	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	A3G	_	NN	_	_	11	NMOD	_	_
11	regulation	_	NN	_	_	9	PMOD	_	_
12	.	_	.	_	_	6	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	4	VMOD	_	_
3	also	_	RB	_	_	4	VMOD	_	_
4	provide	_	VBP	_	_	0	ROOT	_	_
5	information	_	NN	_	_	4	VMOD	_	_
6	about	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	regulation	_	NN	_	_	6	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	APOBEC3F	_	NN	_	_	9	PMOD	_	_
11	(	_	(	_	_	12	P	_	_
12	A3F	_	NN	_	_	10	PRN	_	_
13	)	_	)	_	_	12	P	_	_
14	,	_	,	_	_	10	P	_	_
15	another	_	DT	_	_	16	NMOD	_	_
16	member	_	NN	_	_	10	APPO	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	the	_	DT	_	_	21	NMOD	_	_
19	human	_	JJ	_	_	21	NMOD	_	_
20	APOBEC3	_	NN	_	_	21	NMOD	_	_
21	family	_	NN	_	_	17	PMOD	_	_
22	.	_	.	_	_	4	P	_	_
		
1	A3F	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	expressed	_	VBN	_	_	2	VC	_	_
4	in	_	IN	_	_	3	VMOD	_	_
5	many	_	JJ	_	_	7	NMOD	_	_
6	human	_	JJ	_	_	7	NMOD	_	_
7	tissues	_	NNS	_	_	4	PMOD	_	_
8	that	_	WDT	_	_	10	VMOD	_	_
9	also	_	RB	_	_	10	VMOD	_	_
10	express	_	VBP	_	_	7	NMOD	_	_
11	A3G	_	NN	_	_	10	VMOD	_	_
12	and	_	CC	_	_	2	COORD	_	_
13	both	_	DT	_	_	14	NMOD	_	_
14	proteins	_	NNS	_	_	15	VMOD	_	_
15	have	_	VBP	_	_	12	CONJ	_	_
16	been	_	VBN	_	_	15	VC	_	_
17	shown	_	VBN	_	_	16	VC	_	_
18	to	_	TO	_	_	17	VMOD	_	_
19	form	_	VB	_	_	18	IM	_	_
20	heteromultimers	_	NNS	_	_	19	VMOD	_	_
21	,	_	,	_	_	20	P	_	_
22	which	_	WDT	_	_	23	VMOD	_	_
23	are	_	VBP	_	_	20	NMOD	_	_
24	most	_	RBS	_	_	25	AMOD	_	_
25	likely	_	RB	_	_	23	VMOD	_	_
26	generated	_	VBN	_	_	23	VC	_	_
27	through	_	IN	_	_	26	VMOD	_	_
28	binding	_	NN	_	_	27	PMOD	_	_
29	to	_	TO	_	_	28	NMOD	_	_
30	an	_	DT	_	_	32	NMOD	_	_
31	RNA	_	NN	_	_	32	NMOD	_	_
32	intermediate	_	NN	_	_	29	PMOD	_	_
33	(	_	(	_	_	34	P	_	_
34	26,29,30	_	NN	_	_	32	PRN	_	_
35	)	_	)	_	_	34	P	_	_
36	.	_	.	_	_	2	P	_	_
		
1	A3F	_	NN	_	_	3	VMOD	_	_
2	only	_	RB	_	_	3	VMOD	_	_
3	differs	_	VBZ	_	_	0	ROOT	_	_
4	in	_	IN	_	_	3	VMOD	_	_
5	16	_	CD	_	_	6	NMOD	_	_
6	nt	_	NN	_	_	4	PMOD	_	_
7	from	_	IN	_	_	3	VMOD	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	560	_	CD	_	_	10	NMOD	_	_
10	nt	_	NNS	_	_	7	PMOD	_	_
11	upstream	_	JJ	_	_	10	NMOD	_	_
12	of	_	IN	_	_	11	AMOD	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	TSS	_	NN	_	_	12	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	A3G	_	NN	_	_	15	PMOD	_	_
17	(	_	(	_	_	19	P	_	_
18	GenBank(TM)	_	NN	_	_	19	NMOD	_	_
19	DQ146365	_	CD	_	_	16	PRN	_	_
20	and	_	CC	_	_	19	COORD	_	_
21	DQ147772	_	CD	_	_	20	CONJ	_	_
22	)	_	)	_	_	19	P	_	_
23	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	5	NMOD	_	_
2	180-bp	_	JJ	_	_	5	NMOD	_	_
3	core	_	NN	_	_	5	NMOD	_	_
4	promoter	_	NN	_	_	5	NMOD	_	_
5	region	_	NN	_	_	12	VMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	which	_	WDT	_	_	9	VMOD	_	_
8	we	_	PRP	_	_	9	VMOD	_	_
9	identified	_	VBN	_	_	5	NMOD	_	_
10	for	_	IN	_	_	9	VMOD	_	_
11	A3G	_	NN	_	_	10	PMOD	_	_
12	has	_	VBZ	_	_	0	ROOT	_	_
13	100	_	CD	_	_	14	AMOD	_	_
14	%	_	NN	_	_	15	NMOD	_	_
15	identity	_	NN	_	_	12	VMOD	_	_
16	with	_	IN	_	_	15	NMOD	_	_
17	the	_	DT	_	_	19	NMOD	_	_
18	A3F	_	NN	_	_	19	NMOD	_	_
19	sequence	_	NN	_	_	16	PMOD	_	_
20	.	_	.	_	_	12	P	_	_
		
1	Therefore	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	Sp1/Sp3	_	NN	_	_	5	NMOD	_	_
4	transcription	_	NN	_	_	5	NMOD	_	_
5	factors	_	NNS	_	_	6	VMOD	_	_
6	are	_	VBP	_	_	0	ROOT	_	_
7	most	_	RBS	_	_	8	AMOD	_	_
8	likely	_	RB	_	_	6	VMOD	_	_
9	also	_	RB	_	_	6	VMOD	_	_
10	mediating	_	VBG	_	_	6	VC	_	_
11	basal	_	JJ	_	_	12	NMOD	_	_
12	transcription	_	NN	_	_	10	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	A3F	_	NN	_	_	16	NMOD	_	_
16	gene	_	NN	_	_	13	PMOD	_	_
17	.	_	.	_	_	6	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	study	_	NN	_	_	3	VMOD	_	_
3	revealed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	the	_	DT	_	_	8	NMOD	_	_
6	human	_	JJ	_	_	8	NMOD	_	_
7	A3G	_	NN	_	_	8	NMOD	_	_
8	gene	_	NN	_	_	9	VMOD	_	_
9	is	_	VBZ	_	_	4	SUB	_	_
10	controlled	_	VBN	_	_	9	VC	_	_
11	by	_	IN	_	_	10	VMOD	_	_
12	a	_	DT	_	_	13	NMOD	_	_
13	promoter	_	NN	_	_	11	PMOD	_	_
14	with	_	IN	_	_	13	NMOD	_	_
15	multiple	_	JJ	_	_	18	NMOD	_	_
16	transcriptional	_	JJ	_	_	18	NMOD	_	_
17	start	_	NN	_	_	18	NMOD	_	_
18	sites	_	NNS	_	_	14	PMOD	_	_
19	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	9	VMOD	_	_
2	A3.01	_	NN	_	_	4	NMOD	_	_
3	T	_	NN	_	_	4	NMOD	_	_
4	cells	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	9	P	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	A3G	_	NN	_	_	8	NMOD	_	_
8	promoter	_	NN	_	_	9	VMOD	_	_
9	appears	_	VBZ	_	_	0	ROOT	_	_
10	constitutively	_	RB	_	_	11	AMOD	_	_
11	active	_	JJ	_	_	9	VMOD	_	_
12	and	_	CC	_	_	9	COORD	_	_
13	is	_	VBZ	_	_	12	CONJ	_	_
14	not	_	RB	_	_	13	VMOD	_	_
15	inducible	_	JJ	_	_	13	VMOD	_	_
16	by	_	IN	_	_	15	AMOD	_	_
17	TPA	_	NN	_	_	23	NMOD	_	_
18	,	_	,	_	_	23	P	_	_
19	type	_	NN	_	_	23	NMOD	_	_
20	I	_	CD	_	_	23	NMOD	_	_
21	or	_	CC	_	_	20	COORD	_	_
22	II	_	CD	_	_	21	CONJ	_	_
23	interferons	_	NNS	_	_	16	PMOD	_	_
24	or	_	CC	_	_	16	COORD	_	_
25	by	_	IN	_	_	24	CONJ	_	_
26	HIV-1	_	NN	_	_	27	NMOD	_	_
27	proteins	_	NNS	_	_	25	PMOD	_	_
28	.	_	.	_	_	9	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	core	_	NN	_	_	3	NMOD	_	_
3	promoter	_	NN	_	_	4	VMOD	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	located	_	JJ	_	_	4	VMOD	_	_
6	within	_	IN	_	_	5	AMOD	_	_
7	a	_	DT	_	_	8	NMOD	_	_
8	region	_	NN	_	_	6	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	180	_	CD	_	_	11	NMOD	_	_
11	bp	_	NN	_	_	9	PMOD	_	_
12	at	_	IN	_	_	5	AMOD	_	_
13	position	_	NN	_	_	12	PMOD	_	_
14	-114/+66	_	CD	_	_	13	NMOD	_	_
15	relative	_	JJ	_	_	13	NMOD	_	_
16	to	_	TO	_	_	15	AMOD	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	TSS	_	NN	_	_	16	PMOD	_	_
19	.	_	.	_	_	4	P	_	_
		
1	A	_	DT	_	_	2	NMOD	_	_
2	GC-box	_	NN	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	crucial	_	JJ	_	_	3	VMOD	_	_
5	to	_	TO	_	_	4	AMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	function	_	NN	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	core	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	8	PMOD	_	_
12	and	_	CC	_	_	3	COORD	_	_
13	represents	_	VBZ	_	_	12	CONJ	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	binding	_	VBG	_	_	16	NMOD	_	_
16	site	_	NN	_	_	13	VMOD	_	_
17	for	_	IN	_	_	16	NMOD	_	_
18	Sp1	_	NN	_	_	17	PMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	Sp3	_	NN	_	_	19	CONJ	_	_
21	transcription	_	NN	_	_	22	NMOD	_	_
22	factors	_	NNS	_	_	20	COORD	_	_
23	.	_	.	_	_	3	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	can	_	MD	_	_	0	ROOT	_	_
4	serve	_	VB	_	_	3	VC	_	_
5	as	_	IN	_	_	4	VMOD	_	_
6	a	_	DT	_	_	7	NMOD	_	_
7	basis	_	NN	_	_	5	PMOD	_	_
8	for	_	IN	_	_	7	NMOD	_	_
9	future	_	JJ	_	_	10	NMOD	_	_
10	studies	_	NNS	_	_	8	PMOD	_	_
11	aimed	_	VBN	_	_	10	APPO	_	_
12	at	_	IN	_	_	11	VMOD	_	_
13	understanding	_	VBG	_	_	12	PMOD	_	_
14	how	_	WRB	_	_	19	VMOD	_	_
15	A3G	_	NN	_	_	18	NMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	A3F	_	NN	_	_	16	CONJ	_	_
18	expression	_	NN	_	_	19	VMOD	_	_
19	is	_	VBZ	_	_	13	VMOD	_	_
20	controlled	_	VBN	_	_	19	VC	_	_
21	in	_	IN	_	_	20	VMOD	_	_
22	different	_	JJ	_	_	23	NMOD	_	_
23	tissues	_	NNS	_	_	21	PMOD	_	_
24	and	_	CC	_	_	19	COORD	_	_
25	how	_	WRB	_	_	29	VMOD	_	_
26	these	_	DT	_	_	28	NMOD	_	_
27	restriction	_	NN	_	_	28	NMOD	_	_
28	factors	_	NNS	_	_	29	VMOD	_	_
29	can	_	MD	_	_	24	CONJ	_	_
30	be	_	VB	_	_	29	VC	_	_
31	used	_	VBN	_	_	30	VC	_	_
32	to	_	TO	_	_	31	VMOD	_	_
33	develop	_	VB	_	_	32	IM	_	_
34	novel	_	JJ	_	_	36	NMOD	_	_
35	therapeutic	_	JJ	_	_	36	NMOD	_	_
36	strategies	_	NNS	_	_	33	VMOD	_	_
37	against	_	IN	_	_	33	VMOD	_	_
38	HIV-1	_	NN	_	_	39	NMOD	_	_
39	infection	_	NN	_	_	37	PMOD	_	_
40	.	_	.	_	_	3	P	_	_
		
